PRAX - Praxis Precision Medicines GAAP EPS of -$0.49 beats by $0.17 revenue of $0.78M August, 09 2023 12:18 PM Praxis Precision Medicines Inc. 2023-08-09 12:18:38 ET Praxis Precision Medicines press release ( NASDAQ: PRAX ): Q2 GAAP EPS of -$0.49 beats by $0.17 . Revenue of $0.78M. For further details see: Praxis Precision Medicines GAAP EPS of -$0.49 beats by $0.17, revenue of $0.78M